Fresenius Medical Care, North America, Waltham.
Massachusetts General Hospital, Boston, MA.
Am J Kidney Dis. 2018 Nov;72(5):673-681. doi: 10.1053/j.ajkd.2018.04.004. Epub 2018 Jun 15.
RATIONALE & OBJECTIVE: The relationship between tobacco smoking and comorbid condition outcomes in hemodialysis (HD) patients is not well understood. This study examined the association of tobacco smoking status with hospitalization and mortality in HD patients.
Retrospective cohort study.
SETTING & PARTICIPANTS: Adult HD patients at 2,223 US dialysis centers with HD vintage of 30 days or less who completed a tobacco smoking status survey as part of standard care between April 2013 and June 2015.
Tobacco smoking category: never smoked, currently living with smoker, former smoker, moderate smoker (<1 pack per day), or heavy smoker (≥1 pack per day).
Death and hospital admissions within 2 years of the tobacco smoking survey.
Kaplan-Meier analysis and Cox proportional hazards regression for time to death; cumulative incidence function and Cox proportional hazards regression for time to first hospitalization; negative-binomial regression for number of hospitalizations.
Of 22,230 patients studied, 13% were active smokers. Mortality probabilities increased with greater exposure to smoking (17%, 22%, 23%, and 27% for never, moderate, former, and heavy smokers, respectively; P<0.001), as did incidence rates for first hospitalization (23%, 27%, 27%, and 30%, respectively; P<0.001). Compared to never smoked, heavy smokers had the highest mortality rate (HR for heavy smokers, 1.41 [95% CI, 1.18-1.69]; HR for moderate smokers, 1.39 [95% CI, 1.24-1.55]; HR for former smokers, 1.19 [95% CI, 1.11-1.28]). Living with a smoker was not associated with mortality (HR, 0.93; 95% CI, 0.72-1.22). HRs for first hospitalization followed similar patterns. The incidence rate of mortality for active smokers with diabetes was 173.7/1,000 patient-years and 103.5/1,000 patient-years for those who never smoked (incidence rate ratio, 1.68; P<0.001).
Self-reported survey without detailed history of smoking/cessation.
Risks for death and hospitalization are elevated among HD patients who smoke, being highest among younger individuals and those with diabetes. Second-hand smoke was not associated with poor clinical outcomes.
目前人们对吸烟与血液透析(HD)患者合并症结局之间的关系尚不清楚。本研究旨在探讨吸烟状态与 HD 患者住院和死亡的相关性。
回顾性队列研究。
在美国 2223 家透析中心,纳入在透析 30 天内完成了吸烟状况调查的成年 HD 患者,这些患者接受了标准护理。
吸烟状况类别:从不吸烟、与吸烟者同住、曾经吸烟、轻度吸烟者(每天<1 支)和重度吸烟者(每天≥1 支)。
在接受吸烟状况调查后的 2 年内的死亡和住院情况。
采用 Kaplan-Meier 分析和 Cox 比例风险回归进行死亡时间分析;采用累积发生率函数和 Cox 比例风险回归进行首次住院时间分析;采用负二项回归进行住院次数分析。
在 22230 名患者中,13%为主动吸烟者。随着吸烟量的增加,死亡率也逐渐升高(从不吸烟、轻度、曾经吸烟和重度吸烟者的死亡率分别为 17%、22%、23%和 27%;P<0.001),首次住院的发生率也逐渐升高(分别为 23%、27%、27%和 30%;P<0.001)。与从不吸烟者相比,重度吸烟者的死亡率最高(重度吸烟者的 HR 为 1.41[95%CI,1.18-1.69];中度吸烟者的 HR 为 1.39[95%CI,1.24-1.55];曾经吸烟者的 HR 为 1.19[95%CI,1.11-1.28])。与吸烟者同住并不与死亡率相关(HR 为 0.93[95%CI,0.72-1.22])。首次住院的 HR 也呈现出类似的模式。有糖尿病的吸烟者的死亡率为 173.7/1000 患者年,从不吸烟者的死亡率为 103.5/1000 患者年(发病率比,1.68;P<0.001)。
本研究是基于自我报告的调查,缺乏关于吸烟/戒烟的详细病史。
吸烟的 HD 患者的死亡和住院风险增加,年轻患者和合并糖尿病患者的风险最高。二手烟与不良临床结局无关。